Regulatory Science Update: FDA And International Serious Adverse Events Consortium Complete Third Data Release
The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) announced the third release of data on the genetic basis of drug-induced liver injury (DILI) and serious skin reactions (SSRs). The data focus on the genetics associated with DILI and SSR and may help researchers to better predict an individual’s [...]
Also tagged Consortium, Dili, Fda, Food And Drug, Food And Drug Administration, Genetic Basis, Genetics, Liver Injury, Regulatory Science, Risk, Saec, Serious Adverse Event, Serious Adverse Events, Serious Skin, Ssr
